Skip to main content
. Author manuscript; available in PMC: 2021 Feb 13.
Published in final edited form as: Mol Cancer Res. 2018 Jun 19;16(10):1530–1542. doi: 10.1158/1541-7786.MCR-18-0047

Table 2:

K108 and K440 residues are subject to other PTMs basally and when substituted with arginine residues

Residue PTM Modification ModPred Score Confidence
K108 Ubiquitination 0.54 low
Acetylation 0.53 low
K108R ADP-ribosylation 0.53 low
K108Q Not modified
K440 Acetylated 0.91 High
Ubiquitinated 0.61 low
K440R Methylation 0.79 Medium
K440Q Not modified